Ideaya Biosciences Inc (NASDAQ: IDYA) is -25.89% lower on its value in year-to-date trading and has touched a low of $25.20 and a high of $47.74 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IDYA stock was last observed hovering at around $28.35 in the last trading session, with the day’s loss setting it -1.98%.
Currently trading at $26.37, the stock is -5.54% and -9.86% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.82 million and changing -6.98% at the moment leaves the stock -29.25% off its SMA200. IDYA registered -16.10% loss for a year compared to 6-month loss of -33.46%. The firm has a 50-day simple moving average (SMA 50) of $29.3336 and a 200-day simple moving average (SMA200) of $37.360924.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -10.85% gain in the last 1 month and extending the period to 3 months gives it a -27.17%, and is -2.30% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.35% over the week and 5.09% over the month.
Ideaya Biosciences Inc (IDYA) has around 124 employees, a market worth around $2.28B and $3.92M in sales. Profit margin for the company is -4540.40%. Distance from 52-week low is 4.64% and -44.76% from its 52-week high. The company has generated returns on investments over the last 12 months (-14.85%).
The EPS is expected to shrink by -26.65% this year
306.0 institutions hold shares in Ideaya Biosciences Inc (IDYA), with institutional investors hold 112.35% of the company’s shares. The shares outstanding are 86.36M, and float is at 77.21M with Short Float at 13.03%. Institutions hold 111.18% of the Float.
The top institutional shareholder in the company is FMR LLC with over 11.27 million shares valued at $395.69 million. The investor’s holdings represent 14.4557 of the IDYA Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 6.81 million shares valued at $239.02 million to account for 8.7321 of the shares outstanding. The other top investors are FEDERATED HERMES, INC. which holds 4.86 million shares representing 6.2283 and valued at over $170.49 million, while VANGUARD GROUP INC holds 5.4728 of the shares totaling 4.27 million with a market value of $149.81 million.
Ideaya Biosciences Inc (IDYA) Insider Activity
Ideaya Biosciences Inc disclosed in a document filed with the SEC on May 29 ’24 that WHITE MICHAEL ANTHONY (Chief Scientific Officer) sold a total of 28,500 shares of the company’s common stock. The trade occurred on May 29 ’24 and was made at $36.24 per share for $1.03 million. Following the transaction, the insider now directly holds 0.0 shares of the IDYA stock.
Still, SEC filings show that on May 15 ’24, Hata Yujiro S (President and CEO) disposed off 83,856 shares at an average price of $42.90 for $3.6 million. The insider now directly holds 677,887 shares of Ideaya Biosciences Inc (IDYA).
